Financhill
Back

MBX Biosciences Stock Predictions

MBX Biosciences Stock Forecast

  • Is MBX Biosciences Stock Undervalued?
    The current MBX Biosciences [MBX] share price is $18.50. The Score for MBX is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • MBX is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will MBX Biosciences Stock Go Up Next Year?

Data Unavailable

MBX Biosciences Stock Rating

Data Unavailable

MBX Biosciences Stock Price History

Is MBX stock going to rise?

  • The current trend is relatively stagnant and MBX is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
mbxbio.com

52-Week Data

52-Week High:
27.50
52-Week Low:
15.31

Prediction Charts

Market Cap:
557.84M
Price in USD:
18.50
Volume:
127.31K
Beta:
0.00

Technical Analysis

SMA50:
22.17
SMA100:
0.00
SMA200:
0.00
52-Wk Change:
0%

Stock Predictions

  • Is MBX Biosciences stock public?
    Yes, MBX Biosciences is a publicly traded company.
  • What is the MBX Biosciences stock quote today?
    The MBX Biosciences stock price is 18.50 USD today.
  • How to buy MBX Biosciences stock online?
    You can buy MBX Biosciences shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Nov-5 22.00 23.06 23.88 20.99
Nov-6 23.12 22.75 27.50 22.20
Nov-7 22.53 23.22 23.87 21.44
Nov-8 23.32 22.91 24.30 21.77
Nov-11 21.02 23.50 24.00 21.02
Nov-12 23.33 22.72 23.88 22.22
Nov-13 22.77 20.85 23.89 20.40
Nov-14 21.02 19.49 21.16 19.37
Nov-15 19.30 17.61 20.45 17.00
Nov-18 18.33 16.42 19.16 15.63
Nov-19 15.72 15.94 17.78 15.57
Nov-20 16.34 16.24 16.75 15.31
Nov-21 16.22 16.51 16.61 15.65
Nov-22 16.75 18.50 19.00 16.75

MBX Biosciences Earnings

Data Unavailable

MBX Biosciences Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $2.21 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $10.93 per share.

* MBX Biosciences stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.